— Know what they know.
Not Investment Advice

YDES NASDAQ

YD Bio Limited Ordinary Shares
1W: +41.5% 1M: +115.7% 3M: +246.6% YTD: -32.4% 1Y: -54.7%
$8.11
+0.30 (+3.84%)
 
Weekly Expected Move ±33.0%
$3 $5 $8 $11 $13
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 64 · $574.4M mcap · 1M float · 18.75% daily turnover · Short 48% of daily vol

Balance Sheet Trends

Total Assets
$7M +2037.0% ▲
4Y CAGR: -50.8%
Total Liabilities
$274K -8.1% ▼
4Y CAGR: -64.8%
Shareholders Equity
$7M +28560.7% ▲
4Y CAGR: -49.3%
Cash & Investments
$3M +3496.3% ▲
4Y CAGR: +45.8%
Total Debt
$23K -52.6% ▼
Net Debt
-$3M -7768.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$694K$5K$14K$87K$3M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$694K$5K$14K$87K$3M
Net Receivables$0$0$18K$98K$263K
Inventory$0$0$0$69K$37K
Other Current Assets$0$0$0$0$0
Total Current Assets$831K$130K$203K$272K$3M
Property, Plant & Equip.$0$0$0$14K$88K
Goodwill & Intangibles$0$0$0$0$3M
Long-Term Investments$117M$118M$18M$11K$11M
Other Non-Current Assets$23K$0$0$0-$10M
Total Non-Current Assets$117M$118M$18M$49K$3M
Total Assets$118M$118M$18M$321K$7M
— Liabilities —
Accounts Payable$0$0$0$18K$27K
Short-Term Debt$0$0$0$34K$290
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$302K$2M$6M$344$0
Total Current Liabilities$302K$2M$6M$298K$263K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$18M$7M$1M$2M$4K
Total Non-Current Liabilities$18M$7M$1M$2M$11K
Total Liabilities$18M$9M$7M$298K$274K
— Equity —
Common Stock$115M$115M$18M$105K$144K
Retained Earnings-$15M-$7M-$7M-$515K-$2M
Accumulated OCI$0$0$0$47K$45K
Total Stockholders Equity$100M$109M$11M$23K$7M
Total Liabilities & Equity$118M$118M$18M$321K$7M
— Key Metrics —
Total Debt$0$0$0$48K$23K
Net Debt-$694K-$5K-$14K-$40K-$3M
Total Investments$117M$118M$18M$11K$11M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms